ES2610469T3 - Nuevas formulaciones farmacéuticas útiles en el tratamiento del insomnio - Google Patents

Nuevas formulaciones farmacéuticas útiles en el tratamiento del insomnio Download PDF

Info

Publication number
ES2610469T3
ES2610469T3 ES05798488.2T ES05798488T ES2610469T3 ES 2610469 T3 ES2610469 T3 ES 2610469T3 ES 05798488 T ES05798488 T ES 05798488T ES 2610469 T3 ES2610469 T3 ES 2610469T3
Authority
ES
Spain
Prior art keywords
sublingual
treatment
zolpidem
sleep
study
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05798488.2T
Other languages
English (en)
Spanish (es)
Inventor
Anders Pettersson
Christer Nyström
Susanne Bredenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orexo AB
Original Assignee
Orexo AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orexo AB filed Critical Orexo AB
Application granted granted Critical
Publication of ES2610469T3 publication Critical patent/ES2610469T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES05798488.2T 2004-10-27 2005-10-26 Nuevas formulaciones farmacéuticas útiles en el tratamiento del insomnio Expired - Lifetime ES2610469T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0423800.2A GB0423800D0 (en) 2004-10-27 2004-10-27 New pharmaceutical formulations
GB0423800 2004-10-27
PCT/GB2005/004147 WO2006046041A1 (en) 2004-10-27 2005-10-26 New pharmaceutical formulations useful in the treatment of insomnia

Publications (1)

Publication Number Publication Date
ES2610469T3 true ES2610469T3 (es) 2017-04-27

Family

ID=33515600

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05798488.2T Expired - Lifetime ES2610469T3 (es) 2004-10-27 2005-10-26 Nuevas formulaciones farmacéuticas útiles en el tratamiento del insomnio

Country Status (13)

Country Link
US (4) US9265720B2 (https=)
EP (2) EP1807156B1 (https=)
JP (1) JP5064226B2 (https=)
CY (2) CY1118414T1 (https=)
DK (2) DK2340872T3 (https=)
ES (1) ES2610469T3 (https=)
GB (1) GB0423800D0 (https=)
HU (1) HUE030609T2 (https=)
LT (2) LT2340872T (https=)
PL (2) PL2340872T3 (https=)
PT (2) PT1807156T (https=)
SI (2) SI1807156T1 (https=)
WO (1) WO2006046041A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5179757B2 (ja) 2004-02-17 2013-04-10 トランセプト ファーマシューティカルズ， インコーポレイティド 口腔粘膜を介して催眠剤をデリバリーするための組成物及びその使用方法
EP1883408A4 (en) * 2005-05-25 2009-11-11 Transcept Pharmaceuticals Inc SOLID COMPOSITIONS AND METHODS FOR TREATMENT OF INSOMNIA IN THE NIGHT
US20070287740A1 (en) 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
WO2008067549A2 (en) * 2006-11-30 2008-06-05 Transcept Pharmaceuticals, Inc. Stabilized zolpidem pharmaceutical compositions
WO2008075372A1 (en) * 2006-12-18 2008-06-26 Lupin Limited Controlled release dosage forms of zolpidem
CN101801346A (zh) * 2007-05-10 2010-08-11 诺瓦德尔药品公司 抗失眠症组合物及方法
TR201808694T4 (tr) * 2008-06-20 2018-07-23 Merck Patent Gmbh Doğrudan sıkıştırılabilen ve hızlı parçalanan tablet matrisi.
BRPI1012170A2 (pt) * 2009-05-20 2016-03-29 Lingual Consegna Pty Ltd formulação e/ou sublingual e método para reduzir a quantidade de composto ativo usado para alcançar um efeito em um paciente em comparação com um composto típico que é ingerido.
CN105581991A (zh) * 2015-12-28 2016-05-18 安徽省逸欣铭医药科技有限公司 一种酒石酸唑吡坦舌下片及其制备方法
SG11202103255RA (en) 2018-10-08 2021-04-29 Troikaa Pharmaceuticals Ltd Oromucosal solutions of zolpidem or pharmaceutically acceptable salts thereof
CN111939133A (zh) * 2019-05-16 2020-11-17 鲁南制药集团股份有限公司 一种酒石酸唑吡坦片及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
SE8800080L (sv) 1988-01-13 1989-07-14 Kabivitrum Ab Laekemedelskomposition
SE8803935L (sv) 1988-10-31 1990-05-01 Kabivitrum Ab Laekemedelskomposition
JPH0665103A (ja) * 1992-08-13 1994-03-08 ▲寛▼治 ▲高▼田 向精神薬のための速吸収性舌下投与製剤
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US6200604B1 (en) 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
SE9803239D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
AU7937500A (en) * 1999-10-27 2001-05-08 Farmarc Nederland Bv Pharmaceutical composition containing midazolam
AU5066101A (en) * 2000-04-13 2001-10-30 Synthon B.V. Modified release formulations containing a hypnotic agent
CN1290525A (zh) 2000-10-10 2001-04-11 北京万全阳光医药科技有限公司 冷冻干燥的扎来普隆速溶口服组合物
US20040176359A1 (en) 2001-02-20 2004-09-09 University Of Kentucky Research Foundation Intranasal Benzodiazepine compositions
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
AU2002259241B2 (en) * 2001-05-24 2008-09-04 Alexza Pharmaceuticals, Inc. Delivery of sedative-hypnotics through an inhalation route
ES2301797T3 (es) * 2002-01-10 2008-07-01 Biovail Laboratories International Srl Formulaciones sedantes no benzodiazepinicas.
JP4551092B2 (ja) 2002-03-06 2010-09-22 協和発酵キリン株式会社 口腔内速崩壊性錠剤
US20050208127A1 (en) 2002-06-10 2005-09-22 Kazuyoshi Ogasawara Rapidly disintegrating tablet and process for producing the same
ES2199061B1 (es) 2002-06-10 2005-02-16 Laboratorios Vita, S.A. Comprimidos bucodispersables y procedimiento para su obtencion.
US20050038042A1 (en) * 2002-11-15 2005-02-17 Jenet Codd Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders
CN1418631A (zh) 2002-12-19 2003-05-21 王登之 治疗失眠的佐匹克隆口腔崩解片及其制备方法
US20040265375A1 (en) 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
WO2004100857A2 (en) * 2003-05-07 2004-11-25 Akina, Inc. Highly plastic granules for making fast melting tablets
WO2005063248A1 (en) * 2003-12-22 2005-07-14 Sepracor Inc. Modafinil combination therapy for improving sleep quality
NZ548856A (en) 2004-02-17 2009-10-30 Transcept Pharmaceuticals Inc Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
JP5179757B2 (ja) * 2004-02-17 2013-04-10 トランセプト ファーマシューティカルズ， インコーポレイティド 口腔粘膜を介して催眠剤をデリバリーするための組成物及びその使用方法
CN1290525C (zh) * 2004-07-13 2006-12-20 赵余庆 一种降血糖的植物提取物及其用途

Also Published As

Publication number Publication date
US20080311208A1 (en) 2008-12-18
CY1119580T1 (el) 2018-03-07
GB0423800D0 (en) 2004-12-01
PT1807156T (pt) 2017-01-19
US20110268796A1 (en) 2011-11-03
EP2340872A1 (en) 2011-07-06
HUE030609T2 (en) 2017-05-29
EP1807156B1 (en) 2016-10-12
LT1807156T (lt) 2016-12-12
LT2340872T (lt) 2017-09-11
US20130230589A1 (en) 2013-09-05
US9597281B2 (en) 2017-03-21
PL2340872T3 (pl) 2017-12-29
SI2340872T1 (sl) 2017-10-30
JP2008517988A (ja) 2008-05-29
CY1118414T1 (el) 2017-06-28
JP5064226B2 (ja) 2012-10-31
US9265720B2 (en) 2016-02-23
WO2006046041A1 (en) 2006-05-04
PL1807156T3 (pl) 2017-06-30
SI1807156T1 (sl) 2017-01-31
DK2340872T3 (en) 2017-09-18
EP2340872B1 (en) 2017-07-05
PT2340872T (pt) 2017-10-06
EP1807156A1 (en) 2007-07-18
US20120277261A1 (en) 2012-11-01
DK1807156T3 (en) 2017-01-23

Similar Documents

Publication Publication Date Title
CN102078310B (zh) 大体线性的泡腾口服芬太尼剂型和施用方法
US8119158B2 (en) Effervescent oral fentanyl dosage form and methods of administering fentanyl
ES2706407T3 (es) Composiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona
ES2538460T3 (es) Nueva composición farmacéutica resistente al abuso para el tratamiento de la dependencia de opioides
US20160158225A1 (en) Sustained release formulation of naltrexone
Ghosh et al. Drug delivery to the oral cavity: molecules to market
US9597281B2 (en) Pharmaceutical formulations useful in the treatment of insomnia
MXPA06007453A (es) Forma de dosificacion de opiaceo oral efervescente.
ES2749800T3 (es) Formulación de liberación sostenida de naltrexona
WO2020180608A1 (en) Dipivefrin orally disintegrating tablet formulations
ES2614757T3 (es) Nueva composición de alfentanilo para el tratamiento del dolor agudo
ES2241803T3 (es) Forma galenica oral novedosa con liberacion prolongada de la molsidomina.
ES2642213T3 (es) Nuevas formulaciones farmacéuticas útiles en el tratamiento del insomnio
CN1901890B (zh) 大体线性的泡腾口服芬太尼剂型和施用方法
WO2025012877A1 (es) Composición farmacéutica orodispersable de clonazepam
MXPA06007449A (en) Generally linear effervescent oral fentanyl dosage form and methods of administering